Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal stem cells in emphysema alveolar repair study
NL-OMON43398Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of mesenchymal stem cells in emphysema, chronic obstructive pulmonary disease (COPD) and chronic bronchitis (CB) (2 cohorts), sponsored by University Medical Center Groningen. Primary endpoints: Feasibility of mesenchymal stem cell derivation, Mesenchymal stem cell self-renewal and differentiation and 7 more. Started Mar 2016; status: active, not recruiting.
02
Drugs
mesenchymal stem cells
03
Conditions
emphysemachronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on NL-OMON43398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43398.